Daniel S. Jonas - Apr 28, 2023 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Special Counsel & Corp Secy
Signature
Daniel S. Jonas
Stock symbol
CNMD
Transactions as of
Apr 28, 2023
Transactions value $
-$284,143
Form type
4
Date filed
5/2/2023, 04:19 PM
Previous filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Gift $0 -626 -4.44% $0.00 13.5K Apr 28, 2023 Direct
transaction CNMD Common Stock Options Exercise $977K +10K +74.28% $97.69 23.5K Apr 28, 2023 Direct
transaction CNMD Common Stock Sale -$691K -5.5K -23.44% $125.57 18K Apr 28, 2023 Direct F1
transaction CNMD Common Stock Sale -$545K -4.3K -23.94% $126.72 13.7K Apr 28, 2023 Direct F2
transaction CNMD Common Stock Sale -$25.5K -200 -1.46% $127.56 13.5K Apr 28, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -10K -50% $0.00 10K Apr 28, 2023 Common Stock 10K $97.69 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.30 to $126.25. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.36 to $127.26. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder,
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.42 to $127.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period